RecruitingNot ApplicableNCT06377124

A Smart Self-Management Support Programme (3S) to Improve Quality of Life in Lung Cancer Patients

A Smart Self-Management Support Programme (3S) to Improve Quality of Life in Patients With Lung Cancer - A Pragmatic Randomized Controlled Trial With Mixed-method Evaluation

Sponsor

The University of Hong Kong

Enrollment

320 participants

Start Date

Apr 22, 2024

Study Type

INTERVENTIONAL

Conditions

Lung Cancer

Summary

Lung cancers patients often experience multiple symptoms (e.g. fatigue, dyspnea, distress, depression, sleep disturbance). The current study attempts to explore the efficacy of the Smart Self-Management Support Programme (3S) in improving quality of life of patients using self-management support programme with mobile devices.

Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a digital self-management program (delivered via WhatsApp or WeChat on a smartphone) designed to improve the quality of life and well-being of Chinese-speaking patients with advanced lung cancer. **You may be eligible if...** - You are 18 or older with advanced (stage III or IV) non-small cell lung cancer - You are physically mobile and able to do most daily activities on your own (ECOG score 2 or less) - You speak and read Chinese - You have a smartphone with WhatsApp or WeChat installed - You are currently receiving or have finished cancer treatment **You may NOT be eligible if...** - You are preparing for lung surgery - You have bone fragility, serious active infection, or cannot walk - You have untreated brain metastases causing symptoms - You have severe breathing difficulty, uncontrolled pain, or an active psychiatric illness Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORAL3S intervention

The 3S intervention includes information and support related to self-management of lung cancer, including 1. an individual 3S session at baseline, 2. 24-week messaging, telephone coaching and hotline services.

BEHAVIORALGH information

The GH information includes information related to general health, including 1. an individual GH session at baseline, 2. 24-week messaging, telephone coaching and hotline services.

Locations(3)

Queen Elizabeth Hospital

Hong Kong, Ho ManTin, Hong Kong

Queen Mary Hospital

Hong Kong, Hong Kong

United Christian Hospital

Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06377124

Related Trials

Evaluation for NCI Surgery Branch Clinical Research Protocols

NCT000018231 location

Feasibility of Evaluating Gene Alteration Analysis Using Samples Obtained by EBUS-TBNA in Patients With Lung Cancer

NCT014876031 location

A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation

NCT051188542 locations

Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients With Non-small Cell Lung Cancer Pursuing Stereotactic Body Radiotherapy (SBRT)

NCT017865901 location

Standard Follow-up Program (SFP) for Lung Cancer Patients Treated With Radiotherapy or Chemoradiation

NCT024217181 location